Loading
The European guideline for colon cancer that has not spread: who needs chemotherapy after the operation, for how long, and how patients are followed afterwards.
ESMO Clinical Practice Guidelines for localised colon cancer, published in Annals of Oncology in 2020 by Argilés, Tabernero, Labianca, Hochhauser, Salazar, Iveson, Laurent-Puig, Quirke, Yoshino, Taieb, Martinelli and Arnold for the ESMO Guidelines Committee. Europe PMC indexes no abstract for this article, so OnCo carries no figures from it.
It is the document that turned the IDEA collaboration's duration result into practice in Europe: three months of CAPOX for lower-risk stage III disease, six months of FOLFOX or CAPOX for T4 or N2 disease, and no adjuvant chemotherapy for mismatch repair-deficient stage II disease.
The European rulebook for what happens after a colon cancer operation, and the reason a patient with a T3 N1 tumour is now offered three months of chemotherapy rather than six.
Shares Josep Tabernero, ESMO Clinical Practice Guidelines & MCBS, European Society for Medical Oncology (ESMO), Annals of Oncology and the tag colorectal-evidence.
Shares CAPOX (capecitabine, oxaliplatin), Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Neoadjuvant / adjuvant / perioperative, FOLFOX (5-FU, leucovorin, oxaliplatin) and the tag colorectal-evidence.
Shares ESMO Clinical Practice Guidelines & MCBS, European Society for Medical Oncology (ESMO), Annals of Oncology, Neoadjuvant / adjuvant / perioperative and the tag colorectal-evidence.
Shares Duration of adjuvant chemotherapy for stage III colon cancer (the IDEA collaboration), Josep Tabernero, Neoadjuvant / adjuvant / perioperative, FOLFOX (5-FU, leucovorin, oxaliplatin) and the tag colorectal-evidence.
Shares Duration of adjuvant chemotherapy for stage III colon cancer (the IDEA collaboration), CAPOX (capecitabine, oxaliplatin), Neoadjuvant / adjuvant / perioperative, FOLFOX (5-FU, leucovorin, oxaliplatin) and the tag colorectal-evidence.
Shares Duration of adjuvant chemotherapy for stage III colon cancer (the IDEA collaboration), Colon cancer (adenocarcinoma of the colon), Colorectal cancer and the tag colorectal-evidence.
Shares Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR), Neoadjuvant / adjuvant / perioperative, Colon cancer (adenocarcinoma of the colon), Colorectal cancer and the tag colorectal-evidence.
Shares Neoadjuvant / adjuvant / perioperative, Colon cancer (adenocarcinoma of the colon), Colorectal cancer and the tag colorectal-evidence.